Aruene
Baltimore, US · Founded 2020 · Delaware corporation
Founders & leadership
DR
David RosenChief Executive Officer and Director
SS
Spencer SeguraTreasurer, Secretary and Director
Board
TK
Thomas KnoxBoard director
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2021–2023
▶$3.1MraisedJul 2023 · 20 investors · Other Health CareRule 506(b)
▶$3.1MraisedJul 2023 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David RosenExecutive Officer, Director
- Thomas KnoxDirector
- Spencer SeguraExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.1M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.9MraisedMay 2022 · 8 investors · Other Health CareRule 506(b)
▶$2.9MraisedMay 2022 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas KnoxDirector
- Spencer SeguraExecutive Officer, Director, Promoter
- David RosenExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $2.9M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aruene raised?
- Aruene has disclosed $6M raised across 2 rounds.
- Where is Aruene headquartered?
- Aruene is headquartered in Baltimore, US.